Page 2 - Project Nextgen News Today

CHATHAM, N.J., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of development candidates,

By Chris Wack Capricor Therapeutics shares were up 7% at $4.42 after the company said its proprietary StealthX exosome-based multivalent vaccine for the...

The JN.1 variant, while causing a spike in cases and worse outcomes, isn’t expected to be the sky-is-falling-variant many have worried about. But what if the next one is? Will we be prepared?

Vaccines delivered through the nose or mouth should help stop infection where it begins. But researchers are still working to prove it.

ATCC, the world’s premier biological materials management and standards organization, today announced a five-year, $87 million award from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, to support the development of next-generation medical countermeasures (MCMs) to protect Americans from public health security threats such as coronaviruses.

Today's Water Cooler

Today's Water Cooler

Led by healthcare-focused institutional investors. $30 million financing upfront with up to an additional $114 million tied to the exercise of warrants. CHATHAM, N.J., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Tonix

GHTC is reflecting on the biggest global health innovation stories of 2023.

Vaccines delivered through the nose or mouth should help stop infection where it begins. But researchers are still working to collect the data they need to prove it.